Qlife announced that its core patent for the Egoo system has been granted in the EU and other countries in the European market, as well as in the United Kingdom. The key feature of the innovation is the ability to perform analysis in a microenvironment with fixed alignment, so no variability is seen between analysis and readout. The new patent is already carried on to international markets beyond Europe and provides Qlife with a robust intellectual property position as the company moves towards commercialization.